Management
About Andrew Kamholz, Ph.D.:
Andrew Kamholz has worked in microfluidics since 1994. After earning a B.S. in biomedical engineering while researching blood flow in capillaries at the Johns Hopkins University in 1996, Andrew joined Paul Yager's microfluidics group at the University of Washington. There, while earning his Ph.D. in bioengineering, he studied microfabrication, optics, diffusion, and various microfluidic assay systems. After graduating in 2001, he worked for MesoSystems Technology, which specializes in monitoring and collection of airborne biological threats. There, he helped direct the company's R&D efforts, including integration of MesoSystems' air sampler with microfluidic concentration and detection modules. Most recently, Andrew served as Director of Advanced Development with the Boston division of Tecan, which commercialized the LabCD®, a centrifugal microfluidic assay platform.
In addition, Andrew is a registered patent agent, authorized to act before the US Patent & Trademark office in patent cases. He served both MesoSystems and Tecan Boston as manager of intellectual property and contributed to drafts of all new patent applications.
Andrew is a co-inventor on more than a dozen issued US and foreign patents, the subjects of which include microfluidic sensors, immunoassay, electroosmotic mixing, ferrofluidics, and biological agent screening. He is a co-inventor on more than 50 published patent applications and has authored more than a dozen peer-reviewed scientific articles. Full CV here.